Randomized phase 3 noninferiority trial of radiotherapy and cisplatin vs radiotherapy and cetuximab after docetaxel-cisplatin-fluorouracil induction chemotherapy in patients with locally advanced unresectable head and neck cancer-Reference-Cited by-同舟云学术

Randomized phase 3 noninferiority trial of radiotherapy and cisplatin vs radiotherapy and cetuximab after docetaxel-cisplatin-fluorouracil induction chemotherapy in patients with locally advanced unresectable head and neck cancer

Published:2022-11 Issue: Volume:134 Page:106087
ISSN:1368-8375
Container-title:Oral Oncology
language:en
Short-container-title:Oral Oncology

Author:

Hitt Ricardo,Mesía Ricard,Lozano Alicia,Iglesias Docampo Lara,Grau Juan J.,Taberna Miren,Rubió-Casadevall Jordi,Martínez-Trufero Javier^ORCID,Morillo Edel del Barco,García Girón Carlos,Vázquez Estévez Sergio,Cirauqui Beatriz,Cruz-Hernández Juan Jesús

Funder

Sanofi España

Publisher

Elsevier BV

Subject

Cancer Research,Oncology,Oral Surgery

Reference31 articles.

1. GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries;Bray;CA Cancer J Clin,2018

2. Epidemiologic trends in head and neck cancer and aids in diagnosis;Vigneswaran;Oral Maxillofac Surg Clin North Am,2014

3. Head and Neck Cancer;Longo;N Engl J Med,2020

4. Evidence-Based Treatment Options in Recurrent and/or Metastatic Squamous Cell Carcinoma of the Head and Neck;Argiris;Front Oncol,2017

5. An intergroup phase III comparison of standard radiation therapy and two schedules of concurrent chemoradiotherapy in patients with unresectable squamous cell head and neck cancer;Adelstein;J Clin Oncol,2003

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Anti‑epidermal growth factor receptor monoclonal antibody therapy in locally advanced head and neck cancer: A systematic review of phase III clinical trials;Medicine International;2024-05-29

2. A Network Meta-Analysis of the Systemic Therapies in Unresectable Head and Neck Squamous Cell Carcinoma;Cancer Control;2024-01

3. Cetuximab in squamous cell carcinoma of the head and neck;Revisiones en Cáncer;2024

4. Locally advanced and unresectable squamous cell carcinoma;Revisiones en Cáncer;2024

5. Taxanes in the Treatment of Head and Neck Squamous Cell Carcinoma;Biomedicines;2023-10-25